Almilcar
unknown0.0Global Dominance: 0.00%
Almilcar was mentioned in the context of criticism regarding the procurement practices of medicines under the current administration, indicating potential involvement in financial dealings linked to healthcare acquisitions during López Obrador's government.
Power0
Reach0
Collect
Not in the pool (under ¢1).
Recent news mentions
Almilcar is mentioned in relation to the business of medicine acquisitions.
Federico Döring califica megafarmacia de AMLO como elefante blanco; denuncia saqueo al erario públicoEl Universal·
Mexico· 2025-10-27
Mexico· 2025-10-27
